Rapidly growing non‐tuberculous mycobacterial infection in a renal transplant patient after alemtuzumab induction

Renal transplant recipients are at high risk of developing opportunistic infections particularly in the first 6 months after transplantation. Organisms causing such infections include rapidly growing non‐tuberculous mycobacteria ( NTM ). Lymphocytes have a central role in combating mycobacterial infections. The use of lymphocyte‐depleting agents, such as alemtuzumab, in the renal transplant population has increased in recent years. A case of multifocal osteomyelitis caused by one of the NTM , M ycobacterium chelonae , in a renal transplant recipient, after alemtuzumab induction, is presented.